[Renin-angiotensin system and atherosclerosis]

Area of Science:

• Cardiovascular Science
• Molecular Biology
• Pathogenesis Research

Context:

• Atherosclerosis is a complex disease involving vascular inflammation and smooth muscle cell proliferation.
• The renin-angiotensin system (RAS) plays a critical role in cardiovascular homeostasis.
• Emerging evidence suggests a direct link between RAS activation and atherosclerotic plaque development.

Purpose:

• To review and synthesize literature on the renin-angiotensin system's role in atherosclerosis.
• To elucidate the molecular mechanisms by which Angiotensin II contributes to vascular pathology.
• To evaluate the therapeutic potential of RAS inhibitors in mitigating atherosclerosis.

Summary:

• Literature review indicates Angiotensin II (Ang II) significantly contributes to atherosclerosis pathogenesis.
• Ang II stimulates vascular smooth muscle cells (VSMCs) to produce growth factors (e.g., PDGF, TGF-beta, FGF) and extracellular matrix proteins.
• Evidence shows Ang II upregulates oncogenes (egr-1, c-jun, c-fos, c-myc) in VSMCs, promoting proliferation.
• Inhibition of the RAS reduces VSMC proliferation post-injury, supporting Ang II's pathogenic role.

Impact:

• Highlights the critical role of the renin-angiotensin system in atherosclerosis.
• Provides mechanistic insights into Ang II-mediated vascular smooth muscle cell proliferation.
• Supports the therapeutic strategy of using RAS inhibitors to combat atherosclerosis.